Blue Origin fires up used New Glenn rocket ahead of landmark reflight (photo) - Space
- Blue Origin fires up used New Glenn rocket ahead of landmark reflight (photo) Space
- New Glenn’s Third Mission Slated for April 19 Blue Origin
- Blue Origin's third New Glenn launch faces key reuse test in rivalry with SpaceX Reuters
- Blue Origin hot fires its first previously flown booster, prepares for weekend launch Spaceflight Now
- Blue Origin to stream New Glenn rocket launch. Time, date, how to watch USA Today
Categories: Local News
Khamzat Chimaev not out to hurt Sean Strickland at UFC 328, but ‘on the street… if he dies, he dies’ - MMA Fighting
- Khamzat Chimaev not out to hurt Sean Strickland at UFC 328, but ‘on the street… if he dies, he dies’ MMA Fighting
- Khamzat promises he won’t murder Sean Strickland at UFC 328 — doesn’t rule out killing him in the street mmamania.com
- Khamzat Chimaev dominates Sean Strickland's former rival and top five contender in new camp footage Bloody Elbow
- Dana White Says They're Beefing Up Security For Khamzat Chimaev UFC 328 Defense wrestlinginc.com
- Dana White announces UFC will break new protocol for Khamzat Chimaev vs Sean Strickland fight at UFC 328 The Sun
Categories: Local News
House hands Trump a win with failed Iran war powers vote - Axios
- House hands Trump a win with failed Iran war powers vote Axios
- House effort to end Trump's war with Iran fails by one vote NBC News
- Senate Republicans Again Block Bid to Limit Trump’s Iran War Powers The New York Times
- House Republicans block measure to rein in Trump on Iran as floor debate gets heated MS NOW
- House narrowly rejects limits on Trump as Iran war drags on Politico
Categories: Local News
Utah reports more than 600 measles cases as outbreak spreads across US - The Guardian
- Utah reports more than 600 measles cases as outbreak spreads across US The Guardian
- Utah Becomes the New Center of U.S. Measles Cases The New York Times
- Several preschools exposed to measles as Utah reaches over 600 cases ABC4 Utah
- Utah measles outbreak tops 600 cases, now most active in the US CIDRAP
- Children were exposed to measles at three Washington County schools Utah Public Radio
Categories: Local News
Trump wants less spending. RFK Jr.’s ‘not happy’ about it. - Live Updates - Politico
- Trump wants less spending. RFK Jr.’s ‘not happy’ about it. - Live Updates Politico
- RFK Jr. Shifts Tone on Vaccines in Congressional Hearing The New York Times
- Kennedy Jr. testifies on Trump’s budget on Capitol Hill Honolulu Star-Advertiser
- Four takeaways from RFK Jr.’s contentious House committee hearings The Washington Post
- RFK Jr.’s New Normal The Atlantic
Categories: Local News
Lawmakers clash with RFK Jr as he shifts focus away from vaccines - BBC
Lawmakers clash with RFK Jr as he shifts focus away from vaccines BBCView Full Coverage on Google News
Categories: Local News
They’re Calling It the Saddest Business Pivot of All Time - Slate
- They’re Calling It the Saddest Business Pivot of All Time Slate
- Allbirds stock tumbles after nearly 600% rally as the shoemaker rebrands as an AI company Yahoo Finance
- Allbirds drops sneakers, reinvents itself as an AI infrastructure company Fox Business
- Struggling shoe retailer Allbirds makes bizarre pivot to AI, adds $127 million in value CNBC
- Allbirds shares soar on a very 2026 pivot to AI CNN
Categories: Local News
Kevin Warsh wants to lead a scandal-ridden Fed. His wealth is a complication - CNBC
- Kevin Warsh wants to lead a scandal-ridden Fed. His wealth is a complication CNBC
- Opinion | Three Questions for Kevin Warsh, Trump’s Fed Pick The New York Times
- New Fed chair in an evolving economy: What Warsh might face USA Today
- Senate Democrats move to stall Trump’s ‘absurd’ bid to install new Fed chair The Guardian
- Warsh Hearing Will Test How Far He’ll Push Balance Sheet Reform Bloomberg
Categories: Local News
Kevin Warsh wants to lead a scandal-ridden Fed. His wealth is a complication. - CNBC
- Kevin Warsh wants to lead a scandal-ridden Fed. His wealth is a complication. CNBC
- Democrats Make Final Push to Delay Confirmation Hearing of Trump’s Fed Pick The New York Times
- Senate Democrats move to stall Trump’s ‘absurd’ bid to install new Fed chair The Guardian
- Confirmation hearing set for Trump’s Fed chair nominee CNN
- Fed chair nominee Kevin Warsh is worth more than $100 million and has stakes in SpaceX and Polymarket Fortune
Categories: Local News
Kevin Warsh wants to lead a scandal-ridden Fed. His wealth is a complication. - CNBC
- Kevin Warsh wants to lead a scandal-ridden Fed. His wealth is a complication. CNBC
- Democrats Make Final Push to Delay Confirmation Hearing of Trump’s Fed Pick The New York Times
- Senate Democrats move to stall Trump’s ‘absurd’ bid to install new Fed chair The Guardian
- Confirmation hearing set for Trump’s Fed chair nominee CNN
- Fed chair nominee Kevin Warsh is worth more than $100 million and has stakes in SpaceX and Polymarket Fortune
Categories: Local News
Making games in a war zone: Metro 2039’s Ukrainian developers speak out - Ars Technica
- Making games in a war zone: Metro 2039’s Ukrainian developers speak out Ars Technica
- Metro 2039 revealed as the post-apocalyptic shooter series returns PlayStation.Blog
- Tune in on Thursday for Xbox First Look: Metro 2039 Xbox Wire
- A first look at Metro 2039 shows how its Ukrainian developer turned the darkness up to 11 Engadget
- Xbox First Look: Metro 2039 – Everything We Learned Today from This World Premiere Broadcast Xbox Wire
Categories: Local News
US House rejects war powers resolution aimed at limiting Iran War - BBC
- US House rejects war powers resolution aimed at limiting Iran War BBC
- House effort to end Trump's war with Iran fails by one vote NBC News
- Scoop: Democrats eye new strategy after Iran war powers fail Axios
- House Republicans block measure to rein in Trump on Iran as floor debate gets heated MS NOW
- Senate Republicans Again Block Bid to Limit Trump’s Iran War Powers The New York Times
Categories: Local News
Growing number of trauma, brain injuries linked to e-bikes and e-scooters at 1 hospital: Study - abcnews.com
- Growing number of trauma, brain injuries linked to e-bikes and e-scooters at 1 hospital: Study abcnews.com
- E-Bike and Scooter Crashes Are Leading to More Brain Injuries NYU Langone Health
- Menace on the Streets Macleans.ca
- Hospital admissions due to e-bike and e-scooter injuries have spiked in recent years, study says PhillyVoice
- South Florida Experiencing Rise in Injuries with Continued E-bike Popularity Surge floridainjurylawyer-blawg.com
Categories: Local News
What PIF pulling funding for LIV Golf would mean for Newcastle United and its Saudi ownership - The New York Times
- What PIF pulling funding for LIV Golf would mean for Newcastle United and its Saudi ownership The New York Times
- LIV Golf is still going, but its days seem numbered and probably always were ESPN
- LIV Golf Facing Imminent Closure as Saudi Backers Weigh Pulling Funding WSJ
- LIV Golf CEO strikes defiant tone, says league is ‘really excited about where we are’ The New York Times
- Fanatics-Tom Brady Flag Football Deal With Saudis in Peril Front Office Sports
Categories: Local News
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves - CNBC
- RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves CNBC
- Peptides may soon be easier to get amid RFK Jr's push, but experts warn of risks Fox News
- FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS
- Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides MarketWatch
- FDA advisory committee set to weigh taking action on certain unapproved peptides Fierce Pharma
Categories: Local News
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves - CNBC
- RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves CNBC
- Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides MarketWatch
- Applauding FDA's Move Towards Regulatory Clarity on Peptide Therapy Hims & Hers Newsroom
- FDA advisory committee set to weigh taking action on certain unapproved peptides Fierce Pharma
- The Trump administration is looking to experts to weigh in on peptides Scientific American
Categories: Local News
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves - CNBC
- RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves CNBC
- Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides MarketWatch
- Applauding FDA's Move Towards Regulatory Clarity on Peptide Therapy Hims & Hers Newsroom
- FDA advisory committee set to weigh taking action on certain unapproved peptides Fierce Pharma
- The Trump administration is looking to experts to weigh in on peptides Scientific American
Categories: Local News
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves - CNBC
- RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves CNBC
- Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides MarketWatch
- Applauding FDA's Move Towards Regulatory Clarity on Peptide Therapy Hims & Hers Newsroom
- FDA advisory committee set to weigh taking action on certain unapproved peptides Fierce Pharma
- The Trump administration is looking to experts to weigh in on peptides Scientific American
Categories: Local News
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves - CNBC
- RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves CNBC
- Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides MarketWatch
- Applauding FDA's Move Towards Regulatory Clarity on Peptide Therapy Hims & Hers Newsroom
- FDA advisory committee set to weigh taking action on certain unapproved peptides Fierce Pharma
- The Trump administration is looking to experts to weigh in on peptides Scientific American
Categories: Local News
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves - CNBC
- RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves CNBC
- Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides MarketWatch
- Applauding FDA's Move Towards Regulatory Clarity on Peptide Therapy Hims & Hers Newsroom
- FDA advisory committee set to weigh taking action on certain unapproved peptides Fierce Pharma
- The Trump administration is looking to experts to weigh in on peptides Scientific American
Categories: Local News